other material
confidence high
sentiment neutral
materiality 0.60
Amends $20M patent deal to credit R&D costs; raises $710K via stock sales
MANGOCEUTICALS, INC.
- Amends Patent Purchase Agreement; cash payments reduced to $306K from $373K as of Dec 31, 2024.
- Issued 155,555 shares at $2.25/share for $350K to accredited investor in private placement.
- Received $210K from exercise of 140,000 warrants at $1.50/share on Feb 10.
- Received $150K from exercise of 100,000 warrants at $1.50/share on Feb 11.
- Series B Preferred converted 216 shares (stated value $237,600) into 105,600 common shares.